Tvardi Therapeutics, Inc.

Ownership Transactions Reported by 28 Insiders

Symbol
TVRD on Nasdaq
Location
3 Sugar Creek Ctr. Blvd., Ste 525, Sugar Land, TX

Insiders trading volume in the past year

Tvardi Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Csl Ltd 10%+ Owner $9.02M Aug 9, 2022
Vifor (International) Ltd 10%+ Owner $9.02M Oct 20, 2021
Shaheen Wirk Director $2.23M Apr 17, 2025
Wallace L. Hall Jr Director $1.25M Apr 17, 2025
Derek T. Chalmers President & CEO, Director $1.21M Sep 7, 2021
Martin Vogelbaum Director $308K Jun 4, 2024
Jeffrey L. Ives Director $149K Jun 4, 2024
Lisa von Moltke Director $137K Jun 4, 2024
Helen M. Boudreau Director $113K Jun 4, 2024
Frederique Ph.D. Menzaghi Chief Scientific Off,Svp R&D $92K Feb 1, 2024
Harrison M. Bains Jr Director $70.1K Jun 1, 2023
Christopher Posner PRESIDENT AND CEO, Director $62.3K -$5.59K -8.24% Feb 28, 2025
Thomas Charles Reilly Chief Financial Officer $46.1K Mar 3, 2022
Joana Goncalves Chief Medical Officer $44.3K Apr 5, 2024
Scott Terrillion Sec'y; Chief Compliance & G.C. $34.2K -$776 -2.22% Feb 28, 2025
Richard Makara VP, Head of Accting;Controller $16.6K Jun 15, 2022
Ryan Maynard Chief Financial Officer $7.43K Feb 8, 2024
Samuel D. Tweardy 10%+ Owner $0 Jul 7, 2025
Sujal Shah Director Apr 17, 2025
Avi Daniel Conn Chief Financial Officer Apr 17, 2025
Stephen Paul O'Brien Principal Accounting Officer Apr 17, 2025
Michael S. Wyzga Director Apr 17, 2025
Yixin Chen VP, Chem, Mfg and Ctrls Apr 17, 2025
Imran Nizamudin Alibhai Chief Executive Officer, Director Apr 17, 2025
Jeffrey Leroy Larson SVP, Research & Development Apr 17, 2025
Cynthia Smith Director Apr 17, 2025
Susan Ph.D. Shiff Director Apr 17, 2025
John Saewook M.D. Kauh Chief Medical Officer Apr 17, 2025

Recent Insider Transactions by Companies or Individuals for Tvardi Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.